SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CARE assigns ‘AA-’ rating to Jyothy Laboratories’ proposed NCD

06 Nov 2012 Evaluate

Credit rating agency, CARE has assigned ‘AA-’ rating to Jyothy Laboratories’ proposed long-term Non Convertible Debenture (NCD) worth Rs 50 crore.

The company has received the said rating on the back of growth in its operations coupled with healthy profitability margins and comfortable gearing ratios in FY12.

The company reported 22.35% rise in its net profit at Rs 15.27 crore for the quarter ended September 30, 2012 as compared to Rs 12.48 crore for the same quarter in the previous year. Total income of the company increased by 14.90% at Rs 178.05 crore for quarter under review as compared to Rs 154.96 crore for the quarter ended September 30, 2011.

Jyothy Labs Share Price

238.45 9.40 (4.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2241.10
Godrej Consumer Prod 1108.20
Dabur India 442.10
Colgate Palmol. (I) 2106.20
P&G Hygiene 10006.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×